Life sciences venture capital in emerging markets
Authors:
- Justin ChakmaJCJustin Chakma
- Stephen M SammutSSStephen M Sammut
- Ajay AgrawalAAAjay Agrawal
- 7 March 2013
- journal article
- Published by Springer Nature in Nature Biotechnology
- Vol. 31 (3) , 195-201
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Innovative drug R&D in ChinaNature Reviews Drug Discovery, 2011
- China: a life sciences giantNature Reviews Microbiology, 2010
- Daniel VasellaNature Reviews Drug Discovery, 2010
- China, Globalisation and Health Biotechnology Innovation: Venture Capital and the Adaptive StateEast Asian Science, Technology and Society: an International Journal, 2009
- Small but tenacious: South Africa's health biotech sectorNature Biotechnology, 2009
- A survey of South-North health biotech collaborationNature Biotechnology, 2009
- Is this Singapore's golden era?Nature, 2008
- Brazilian health biotech—fostering crosstalk between public and private sectorsNature Biotechnology, 2008
- Chinese health biotech and the billion-patient marketNature Biotechnology, 2008
- India's health biotech sector at a crossroadsNature Biotechnology, 2007